Notable Labs, Ltd.
NTBLDelisted Mar 5, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001603207
Notable Labs, Ltd. was delisted on Mar 5, 2025; its insiders filed their last Form 4 on May 10, 2024; 16 institutions reported holding it in 13F filings for Q3 2024, worth $197.6K in total; no superinvestor held it.
13F holders, Q2 2023
Institutional positions in Notable Labs, Ltd. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 17
- −1 vs. Q1 2023
- Shares held
- 745.7K
- −76.5K (−9.3%) vs. Q1 2023
- Total value
- $171.8K
- +$34.5K (+25.1%) vs. Q1 2023
- New holders
- 2
- 2 more added
- Sold out
- 3
- 2 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NTBL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 16 | $197.6K |
| Q2 2024 | 17 | $270.3K |
| Q1 2024 | 14 | $611.8K |
| Q4 2023 | 12 | $550.4K |
| Q3 2023 | 22 | $237.1K |
| Q2 2023 | 17 | $171.8K |
| Q1 2023 | 18 | $137.3K |
| Q4 2022 | 28 | $295.1K |
| Q3 2022 | 26 | $517.6K |
| Q2 2022 | 30 | $11.1M |
| Q1 2022 | 26 | $10.8M |
| Q4 2021 | 26 | $15.2M |
| Q3 2021 | 28 | $10.2M |
| Q2 2021 | 23 | $9.16M |
| Q1 2021 | 25 | $5.39M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Notable Labs, Ltd.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 798 | $0 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 100 | $23 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 937 | $216 | 0.00% | 00.0% | Unchanged |
| GWM Advisors LLC | 1,700 | $391 | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 4,000 | $920 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 8,192 | $1.88K | 0.00% | 00.0% | Unchanged |
| Harel Insurance Investments & Financial Services Ltd. | 11,000 | $3.00K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 13,526 | $3.00K | 0.00% | +13,526 | New |
| Spectrum Planning & Advisory Services Inc. | 16,000 | $4.16K | 0.01% | 00.0% | Unchanged |
| HBK Sorce Advisory LLC | 20,575 | $4.73K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 22,491 | $5.20K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 32,900 | $7.57K | 0.00% | +15,100+84.8% | Added |
| Catalyst Financial Partners LLC | 39,000 | $8.97K | 0.00% | +39,000 | New |
| Geode Capital Management, LLC | 40,323 | $9.27K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 79,892 | $18.0K | 0.00% | +42,468+113.5% | Added |
| Group One Trading, L.P. | 127,293 | $29.3K | 0.00% | −43,200−25.3% | Reduced |
| Morgan Stanley | 327,011 | $75.2K | 0.00% | −82,000−20.0% | Reduced |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −39,000−100.0% | Sold out |
| Affinity Capital Advisors, LLC | 0 | $0 | 0.00% | −22,265−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |